"10.1371_journal.pone.0143589","plos one","2015-12-01T00:00:00Z","Nathalie Assayag-Asherie; Dror Sever; Marika Bogdani; Pamela Johnson; Talya Weiss; Ariel Ginzberg; Sharon Perles; Lola Weiss; Lora Eshkar Sebban; Eva A Turley; Elimelech Okon; Itamar Raz; David Naor","The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel; Department of Endocrinology, Hadassah University Hospital, Ein Kerem, Jerusalem 91120, Israel; Matrix Biology Program, Benaroya Research Institute, Seattle, WA, United States of America; Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital Ein Kerem, Hebrew University, Jerusalem, 91120 Israel; London Regional Cancer Center, University of Western Ontario, London, ON, Canada; LEM laboratories Science Park, Rehovot, Israel; Diabetes Unit, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel","Conceived and designed the experiments: NAA. Performed the experiments: NAA DS MB PJ TW SP LW. Analyzed the data: NAA. Contributed reagents/materials/analysis tools: LES EAT. Wrote the paper: NAA DN. Provided help in graphical illustrations and general statistical analysis: AG. Supervised the clinical aspects of the project: IR. Supervised the entire project and all experiments were performed in his lab: DN. Provided histopathological outsourcing services: EO.","This study was funded by Johnson & Johnson. Co-author Elimelech Okon is employed by LEM Laboratories Company. LEM Laboratories Company provided histopathology outsourcing services. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","12","Nathalie Assayag-Asherie","NAA",13,TRUE,1,7,1,2,TRUE,TRUE,FALSE,0,NA,FALSE
